Patterns and trends of amphetamine-type stimulants and other drugs ...

More documents

Recommendations

Info

MDA MDE/MDEA MDMA mg ml mt NACD NADA NCB NCHADS NDARC NDDCB NDIB NDSHS NEP NGO NNB NNCC NPA OECD ONCB P-2-P PAG PCDC PDARN PDEA PDR PIFS PMK RCEAP RMP ROK ROSA SAR SMART SODC SPO SRO STI TFMPP UAE UN UNAIDS UNDP UNGASS UNODC USD YRBSS 2C-B 2C-T-2 3,4-Methylenedioxyamphetamine (tenamfetamine) 3,4-Methylenedioxyethylamphetamine 3,4-Methylenedioxymethamphetamine MSG Mono sodium glutamate miligramme(s) mililitre(s) metric ton(s) National Authority for Combating Drugs (Cambodia) National Anti-Drug Agency (Malaysia) Narcotics Control Bureau (Brunei Darussalam) National Center for HIV/AIDS, Dermatology and Sexually Transmitted Infections for Cambodia National Drug and Alcohol Research Centre (Australia) National Dangerous Drugs Control Board (Sri Lanka) National Drug Intelligence Bureau (New Zealand) National Drug Strategy Household Survey (Thailand) Needle Exchange Programme Non-governmental organization National Narcotics Board Indonesia National Narcotics Control Commission (China) National Police Agency (Japan) Organization for Economic Cooperation and Development Ofce of the Narcotics Control Board (Thailand) 1-Phenyl-2-propanone (BMK) Policy Advisory Group (New Zealand) Provincial Committee for Drug Control (Lao PDR) Pacic Drug and Alcohol Research Network Philippine Drug Enforcement Agency Lao People’s Democratic Republic Pacic Island Forum Secretariat 3,4-Methylenedioxyphenyl-2-propanone (3,4-MDP-2-P) Regional Centre for East Asia and the Paci c (UNODC) Royal Malaysian Police Republic of Korea Regional Ofce for South Asia (UNODC) Special Administrative Region Synthetics Monitoring: Analyses, Reporting and Trends Standing Ofce on Drugs and Crime (formerly Standing Of ce on Drugs Control) (Viet Nam) Supreme Prosecutors’ Of ce (Republic of Korea) Safrole-rich oils Sexually transmitted infections 3-triuoromethylphenyl-piperazine United Arab Emirates United Nations The Joint United Nations Programme on HIV/AIDS United Nations Development Programme United Nations General Assembly Special Session United Nations Ofce on Drugs and Crime United States dollar Youth Risk Behaviour Surveillance System (United States) 4-Bromo-2,5-dimethoxyphenethylamine (Nexus) 4-Ethylthio-2,5-dimethoxyphenethylamine iv
List of Tables and Figures Tables Table 1. Clandestine laboratories dismantled, 200 – 2009 Table 2. Methamphetamine-related arrests in East and Southeast Asia, 2004 – 2009 Table 3. Methamphetamine pill seizures in East and Southeast Asia, 2004 – 2009\ Table 4. Crystalline methamphetamine seizures in East and Southeast Asia, 2004 – 2009 Table 5. Ecstasy-related arrests in East and Southeast Asia, 2004 – 2009 Table 6. ‘Ecstasy’ seizures in East and Southeast Asia, 2004 – 2009 Table 7. Ketamine seizures in East and Southeast Asia, 2004 – 2009 Table 8. Opiate-related arrests in East and Southeast Asia, 2004 – 2009 Table 9. Heroin seizures in East and Southeast Asia, 2004 – 2009 Table 10. Opium seizures in East and Southeast Asia, 2004 – 2009 Table 11. Cannabis-related arrests in East and Southeast Asia, 2004 – 2009 Table 12. Cannabis-related seizures in East and Southeast Asia, 2004 – 2009 Table 13. Status of treaty adherence of selected Paci c Island States and Territories Table 14. Drug use concerns in selected Paci c Island States and Territories Table 15. Drugs reported seized in Bangladesh, 2006 – 2009 Table 16. ATS seizures in India, 2004 – 2009 Table 17. Drug seizures in Sri Lanka, 2004 – 2009 Table 18. Rank of use of selected drugs in Australia, 1995 – 2007 Table 19. Trend of use of selected drugs in Australia, 1995 – 2007 Table 20. Number of drug treatment admissions in Australia by drug type, 2002 – 2003 to 2007 – 2008 Table 21. Illicit drug–related arrests in Australia, 2004 – 2005 to 2008 – 2009 Table 22. Illicit drug–related arrests in Australia, 2004 – 2005 to 2008 – 2009 Table 23. Rank of use of selected drugs in Brunei Darussalam, 2003 – 2009 Table 24. Trend in use of selected drugs in Brunei Darussalam, 2003 – 2009 Table 25. Drug treatment admissions in Brunei Darussalam, 2009 Table 26. Drug-related arrests in Brunei Darussalam by drug type, 2009 Table 27. Seizures of selected drugs in Brunei Darussalam, 2006 – 2009 Table 28. Retail prices of illicit drugs in Brunei Darussalam (USD), 2008 and 2009 Table 29. Rank of use of selected drugs in Cambodia, 2003 – 2009 Table 30. Trend in use of selected drugs in Cambodia, 2003 – 2009 Table 31. Drug-related arrests in Cambodia, 2009 Table 32. Drug-related arrests in Cambodia by drug type, 2004 – 2009 Table 33. Seizures of selected drugs in Cambodia, 2005 – 2009 Table 34. Retail prices of illicit drugs in Cambodia (USD), 2007 – 2008 Table 35. Rank of use of selected drugs in China, 2004 – 2009 Table 36. Trend in use of selected drugs in China, 2004 – 2009 Table 37. Seizures of selected drugs in China, 2005 – 2009 Table 38. Seizures of selected drugs in Hong Kong (SAR), 2005 – 2009 Table 39. Rank of use of selected drugs in Indonesia, 2003 – 2009 Table 40. Trend in use of selected drugs in Indonesia, 2003 – 2009 Table 41. Drug treatment admissions in Indonesia by drug type and gender, 2009 Table 42. Drug-related arrests in Indonesia by drug type and gender, 2009 Table 43. Seizures of selected drugs in Indonesia, 2006 – 2009 Table 44. Retail prices of illicit drugs in Indonesia (USD), 2008 and 2009 Table 45. Rank of use of selected drugs in Japan, 2004 – 2009 Table 46. Trend in use of selected drugs in Japan, 2004 – 2009 Table 47. Drug-related arrests in Japan by drug type, 2005 – 2009 Table 48. Seizures of selected drug in Japan, 2005 – 2009 Table 49. Wholesale and retail price range of drugs Japan (in USD), 2007 and 2008 Table 50. Rank and trend in use of selected drugs in Lao PDR, 2009 Table 51. Rank of use of selected drugs in Lao PDR, 2004 – 2009 Table 52. Number of patients at Somsanga Treatment and Rehabilitation Center, 2003 – 2009 Table 53. Drug-related arrests in Lao PDR by drug type, 2009 Table 54. Seizures of selected drugs in Lao PDR, 2005 – 2009 Table 55. Rank and trend of use of selected drugs in Malaysia, 2009 v
Page 1 and 2: and Other Drugs Asia and the Pacifi
Page 3 and 4: Patterns and Trends of Amphetamine-
Page 5 and 6: Indonesia .........................
Page 7 and 8: Acknowledgements Grateful appreciat
Page 9: Abbreviations ACC ACCORD ADK ADLOMI
Page 13 and 14: Figure 7. Ecstasy use trend, 2009 F
Page 15: Drug use - As there is some scienti
Page 18 and 19: Despite the rising numbers of ATS u
Page 20 and 21: Figure 1. Data integrity process 1.
Page 23 and 24: Regional Trends: East and Southeast
Page 25 and 26: gures reported to date. These inclu
Page 27 and 28: In New Zealand, a total of 2,436 pe
Page 29 and 30: Table 4. Cont. Crystalline methamph
Page 31 and 32: Table 6. Cont. Ecstasy seizures in
Page 33 and 34: Table 7. Ketamine seizures in East
Page 35 and 36: Overall opiate-related arrests in t
Page 37 and 38: Cannabis In 2009, an increasing tre
Page 39 and 40: Other substances Apart from ATS, ca
Page 41 and 42: 6. Increasing activity of transnati
Page 43 and 44: Regional Trends: Pacic Island State
Page 45 and 46: On many islands, there is tradition
Page 47: iour. Similar restrictions over suc
Page 50 and 51: Regional Trends/ South Asia Table 1
Page 52 and 53: Regional Trends/ South Asia Figure
Page 54 and 55: Regional Trends/ South Asia tain bu
Page 57: National Trends in Amphetamine-Type
Page 60 and 61:
Australia Prevalence of recent meth
Page 62 and 63:
Australia Table 21. Cont. Illicit d
Page 64 and 65:
Australia continue to be detected i
Page 66 and 67:
Australia The number of clandestin
Page 68 and 69:
Brunei Darussalam Table 24. Trend i
Page 70 and 71:
in 2009 indicated 245 cases and a t
Page 73 and 74:
CAMBODIA Overview of the drug situa
Page 75 and 76:
Drug-related arrests, seizures and
Page 77:
Table 34. Retail prices of illicit
Page 80 and 81:
China Table 36. Trend in use of sel
Page 82 and 83:
China Figure 23. ATS seizures in Ch
Page 84 and 85:
China Clandestine ATS manufacturing
Page 86 and 87:
Indonesia Table 40. Trend in use of
Page 88 and 89:
Indonesia Annual heroin seizures ha
Page 91 and 92:
JAPAN Overview of the drug situatio
Page 93 and 94:
Table 47. Drug-related arrests in J
Page 95:
Ecstasy (MDMA) is primarily trafcke
Page 98 and 99:
Lao PDR Table 51. Rank of use of se
Page 100 and 101:
Lao PDR ATS precursors, heroin and
Page 102 and 103:
Malaysia The prevalence of IDUs amo
Page 104 and 105:
Malaysia Drug prices - Retail price
Page 107 and 108:
MYANMAR Overview of the drug situat
Page 109 and 110:
In 2009, cannabis-related arrests c
Page 111 and 112:
Table 62. Illicit drug seizures in
Page 113 and 114:
Drug trafcking - Drug trafcking has
Page 115 and 116:
NEW ZEALAND Overview of the drug si
Page 117 and 118:
Drug treatment Hospital admissions
Page 119 and 120:
Table 70. Seizures of selected illi
Page 121:
There is an increased risk of the o
Page 124 and 125:
Philippines Table 73. Rank of use o
Page 126 and 127:
Philippines Drug law enforcement of
Page 128 and 129:
Philippines facture of crystalline
Page 130 and 131:
Republic of Korea Drug treatment In
Page 132 and 133:
Republic of Korea lands (23.8%) wer
Page 134 and 135:
Singapore Table 83. Rank and trend
Page 136 and 137:
Singapore Overall the number of dru
Page 138 and 139:
Singapore Table 91. Retail prices o
Page 140 and 141:
Table 92. Cont. Rank in use of sele
Page 142 and 143:
Thailand Table 95. Drug-related arr
Page 144 and 145:
Thailand Figure 39. Ecstasy seizure
Page 146 and 147:
Thailand Forensic data Most methamp
Page 148 and 149:
Viet Nam Table 99. Trend in use of
Page 150 and 151:
Viet Nam Heroin and opium are frequ
Page 153 and 154:
Data annex (East and Southeast Asia
Page 155 and 156:
Table 101. Cont. Drug-related arres
Page 157 and 158:
Table 102. Drug seizures in East an
Page 159 and 160:
Treatment data Drug treatment data
Page 161 and 162:
Table 103. Total annual treatment a
Page 163 and 164:
Table 104. Rank in use of selected
Page 165 and 166:
Table 105. Reported drug trends in
Page 167 and 168:
References ACC, 2010. ‘Illicit Dr
Page 169 and 170:
drugs and psychotropic substances:
Page 171 and 172:
NDARC, 2009. Submission to UNODC Re
Page 173 and 174:
SODC, 2007. Viet Nam country presen
Page 176:
AUSTRALIA CANADA JAPAN NEW ZEALAND
show all

Patterns and trends of amphetamine-type stimulants and other drugs ...

Create successful ePaper yourself

Delete template?

Save as template?